-
Berenbrok Receives Pharmacy Leadership Award
Faculty affiliate Dr. Lucas Berenbrok received the 2023 Albert B. Prescott Pharmacy Leadership Award. The award recognizes early-career pharmacists who are already strong leaders and will accomplish more in the future.
Read more about the award -
Hernandez & Gellad Write JAMA Editorial
CP3 Director Dr. Walid Gellad and former Associate Director Dr. Inma Hernandez wrote an editorial for JAMA on how the Inflation Reduction Act might affect drug spending in fee-for-service Medicare.
Read the paper here -
Suda Awarded NIH R01
CP3 Associate Director Dr. Katie Suda was awarded another R01 grant from the NIH. This project will examine dentists' prescribing patterns of and attitudes toward high-risk medications to children, and the team will develop guidelines for prescribing these medications to younger patients.
Read more about this project here
Improving the Quality, Safety and Efficiency of Medication Use
While prescription drugs are used by 80% of Americans, the improper, unsafe use of medications leads to billions of dollars of avoidable healthcare costs. The goal of the CP3 research program is to improve patient and prescriber decision-making, and inform the regulation and coverage of pharmaceuticals.
